In this episode of Myeloma Matters, you’ll learn about targeted immunotherapy, a unique type of myeloma treatment that specifically targets myeloma cells. You’ll hear from three patients who have been on a targeted immunotherapy to get a sense of the patient experience and how these patients wound up receiving targeted immunotherapy.
Topics of discussion:
(0:00) Introduction to myeloma and targeted immunotherapy
(17:15) Differences between targeted immunotherapy and traditional drugs
(18:58) Preparing for CAR T-cell therapy compared to an autologous stem cell transplant
(22:34) The role of the caregiver during and after hospitalization for treatment
(32:25) Experience with a bispecific antibody
(36:21) Handling being off treatment after CAR T-cell therapy
To learn more about immunotherapy, download the Multiple Myeloma Immunotherapy booklet here.
To learn more about multiple myeloma, visit www.themmrf.org.
If you want to learn more about the MMRF’s FREE resources for patients and caregivers, visit the MMRF Education Hub.
If you have additional questions, call our MMRF Patient Navigation Center at 1-888-841- 6673.
